|
GB1053063A
(US20080094685A1-20080424-C00004.png)
|
1963-05-18 |
|
|
|
|
US3691016A
(en)
|
1970-04-17 |
1972-09-12 |
Monsanto Co |
Process for the preparation of insoluble enzymes
|
|
DE2027645A1
(de)
|
1970-06-05 |
1971-12-09 |
Byk Gulden Lomberg Chemische Fa bnk GmbH, 7750 Konstanz |
Piperazinylalkyl chinazolon (4) den vate, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
|
|
US3897432A
(en)
|
1971-04-21 |
1975-07-29 |
Merck & Co Inc |
Substituted benzimidazole derivatives
|
|
NL7204972A
(US20080094685A1-20080424-C00004.png)
|
1971-04-21 |
1972-10-24 |
|
|
|
CA1023287A
(en)
|
1972-12-08 |
1977-12-27 |
Boehringer Mannheim G.M.B.H. |
Process for the preparation of carrier-bound proteins
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4195128A
(en)
|
1976-05-03 |
1980-03-25 |
Bayer Aktiengesellschaft |
Polymeric carrier bound ligands
|
|
DE2644265C2
(de)
|
1976-09-30 |
1983-02-10 |
Bayer Ag, 5090 Leverkusen |
Chinazoline
|
|
US4330440A
(en)
|
1977-02-08 |
1982-05-18 |
Development Finance Corporation Of New Zealand |
Activated matrix and method of activation
|
|
CA1093991A
(en)
|
1977-02-17 |
1981-01-20 |
Hideo Hirohara |
Enzyme immobilization with pullulan gel
|
|
US4183931A
(en)
|
1977-09-08 |
1980-01-15 |
Research Corporation |
2-Ketoalkyl-4(3H)-quinazolinones
|
|
US4229537A
(en)
|
1978-02-09 |
1980-10-21 |
New York University |
Preparation of trichloro-s-triazine activated supports for coupling ligands
|
|
DE2812635A1
(de)
|
1978-03-22 |
1979-09-27 |
Bayer Ag |
Heterocyclische verbindungen
|
|
JPS55118917A
(en)
|
1979-03-06 |
1980-09-12 |
Mitsubishi Electric Corp |
Production of quinazolone ring-containing epoxy resin
|
|
JPS55118918A
(en)
|
1979-03-06 |
1980-09-12 |
Mitsubishi Electric Corp |
Production of quinazolone ring-containing epoxy resin
|
|
US4289872A
(en)
|
1979-04-06 |
1981-09-15 |
Allied Corporation |
Macromolecular highly branched homogeneous compound based on lysine units
|
|
JPS6017375B2
(ja)
|
1979-06-20 |
1985-05-02 |
三菱電機株式会社 |
ポリアミド樹脂の製造方法
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
EP0318512B1
(en)
|
1986-08-18 |
1998-06-17 |
Emisphere Technologies, Inc. |
Delivery systems for pharmacological agents
|
|
USRE35862E
(en)
|
1986-08-18 |
1998-07-28 |
Emisphere Technologies, Inc. |
Delivery systems for pharmacological agents encapsulated with proteinoids
|
|
US6696250B1
(en)
|
1986-12-03 |
2004-02-24 |
Competitive Technologies, Inc. |
RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
|
|
US5229490A
(en)
|
1987-05-06 |
1993-07-20 |
The Rockefeller University |
Multiple antigen peptide system
|
|
US5225347A
(en)
|
1989-09-25 |
1993-07-06 |
Innovir Laboratories, Inc. |
Therapeutic ribozyme compositions and expression vectors
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
FR2675803B1
(fr)
|
1991-04-25 |
1996-09-06 |
Genset Sa |
Oligonucleotides fermes, antisens et sens et leurs applications.
|
|
ES2084940T3
(es)
|
1991-06-18 |
1996-05-16 |
American Home Prod |
Uso de la rapamicina para el tratamiento de la leucemia/linfoma de las celulas t adultas.
|
|
CA2118130A1
(en)
|
1992-04-14 |
1993-10-28 |
Jean M. J. Frechet |
Dendritic based macromolecules and method of production
|
|
US5658780A
(en)
|
1992-12-07 |
1997-08-19 |
Ribozyme Pharmaceuticals, Inc. |
Rel a targeted ribozymes
|
|
GB9301000D0
(en)
|
1993-01-20 |
1993-03-10 |
Glaxo Group Ltd |
Chemical compounds
|
|
US5378725A
(en)
|
1993-07-19 |
1995-01-03 |
The Arizona Board Of Regents |
Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
|
|
GB9404485D0
(en)
|
1994-03-09 |
1994-04-20 |
Cancer Res Campaign Tech |
Benzamide analogues
|
|
FI951367A
(fi)
|
1994-03-28 |
1995-09-29 |
Japan Energy Corp |
Puriinijohdannaiset ja tulehdustautien tukahduttajat (suppressantit)
|
|
US5480906A
(en)
|
1994-07-01 |
1996-01-02 |
Eli Lilly And Company |
Stereochemical Wortmannin derivatives
|
|
RU2203669C2
(ru)
|
1994-08-12 |
2003-05-10 |
Про-Нейрон Инк. |
Способы лечения сепсиса и воспалений с помощью оксипуриновых нуклеозидов
|
|
US5561138A
(en)
|
1994-12-13 |
1996-10-01 |
American Home Products Corporation |
Method of treating anemia
|
|
US6043062A
(en)
|
1995-02-17 |
2000-03-28 |
The Regents Of The University Of California |
Constitutively active phosphatidylinositol 3-kinase and uses thereof
|
|
US6096871A
(en)
|
1995-04-14 |
2000-08-01 |
Genentech, Inc. |
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
|
|
US5948664A
(en)
|
1996-02-29 |
1999-09-07 |
The Regents Of The University Of California |
PI 3-kinase polypeptides
|
|
DE69731289D1
(de)
|
1996-03-18 |
2004-11-25 |
Univ Texas |
Immunglobulinähnliche domäne mit erhöhten halbwertszeiten
|
|
JP3241388B2
(ja)
|
1996-05-15 |
2001-12-25 |
ファイザー・インク |
新規２，３二置換―４（３ｈ）―キナゾリノン
|
|
GB9611460D0
(en)
|
1996-06-01 |
1996-08-07 |
Ludwig Inst Cancer Res |
Novel lipid kinase
|
|
US5858753A
(en)
|
1996-11-25 |
1999-01-12 |
Icos Corporation |
Lipid kinase
|
|
TW528755B
(en)
|
1996-12-24 |
2003-04-21 |
Glaxo Group Ltd |
2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
|
|
RU2200161C2
(ru)
|
1996-12-31 |
2003-03-10 |
Др. Редди'З Рисерч Фаундейшн |
Новые производные азолидиндиона, способ их получения (варианты), фармацевтические композиции на их основе, способ предупреждения или лечения, способ снижения глюкозы и промежуточное соединение
|
|
GB9702701D0
(en)
|
1997-02-01 |
1997-04-02 |
Univ Newcastle Ventures Ltd |
Quinazolinone compounds
|
|
SK113299A3
(en)
|
1997-02-28 |
2001-05-10 |
Pfizer Prod Inc |
Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists
|
|
EP0884310B1
(en)
|
1997-06-09 |
2005-09-07 |
Pfizer Products Inc. |
Quinazolin-4-one ampa antagonists
|
|
US6277981B1
(en)
|
1997-07-03 |
2001-08-21 |
Thomas Jefferson University |
Method for design and selection of efficacious antisense oligonucleotides
|
|
IL125950A0
(en)
|
1997-09-05 |
1999-04-11 |
Pfizer Prod Inc |
Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
|
|
EP1044004A1
(en)
|
1998-01-08 |
2000-10-18 |
The University Of Virginia Patent Foundation |
A2a adenosine receptor agonists in combination with a type iv phosphodiesterase inhibitors
|
|
DE69828445D1
(de)
|
1998-04-23 |
2005-02-03 |
Reddys Lab Ltd Dr |
Heterozyklische verbindungen,und deren verwendung in arzneimittel,verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
|
|
US6048970A
(en)
|
1998-05-22 |
2000-04-11 |
Incyte Pharmaceuticals, Inc. |
Prostate growth-associated membrane proteins
|
|
US6100090A
(en)
|
1999-06-25 |
2000-08-08 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of PI3K p85 expression
|
|
US6046049A
(en)
|
1999-07-19 |
2000-04-04 |
Isis Pharmaceuticals Inc. |
Antisense modulation of PI3 kinase p110 delta expression
|
|
DE60028227T2
(de)
|
1999-10-27 |
2007-03-29 |
Cytokinetics, Inc., South San Francisco |
Chinazolinone benutzende verfahren und zusammenstellungen
|
|
CA2396079A1
(en)
*
|
2000-01-07 |
2001-07-19 |
Transform Pharmaceuticals, Inc. |
High-throughput formation, identification, and analysis of diverse solid-forms
|
|
AU2001230426C1
(en)
|
2000-01-24 |
2006-06-22 |
Astrazeneca Ab |
Therapeutic morpholino-substituted compounds
|
|
AU2972701A
(en)
|
2000-02-07 |
2001-08-14 |
Bristol Myers Squibb Co |
3-aminopyrazole inhibitors of cyclin dependent kinases
|
|
PT3029041T
(pt)
|
2000-04-25 |
2020-05-13 |
Icos Corp |
Inibidores de fosfatidil-inositol 3-quinase delta humana
|
|
US6667300B2
(en)
*
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
AU2003247483A1
(en)
|
2002-05-30 |
2003-12-31 |
The Children's Hospital Of Philadelphia |
Methods for treatment of acute lymphocytic leukemia
|
|
RS115904A
(en)
|
2002-07-10 |
2006-12-15 |
Applied Research Systems Ars Holding N.V. |
Azolidinone-vinyl fused benzene derivatives
|
|
US20040092561A1
(en)
|
2002-11-07 |
2004-05-13 |
Thomas Ruckle |
Azolidinone-vinyl fused -benzene derivatives
|
|
GB0217777D0
(en)
|
2002-07-31 |
2002-09-11 |
Novartis Ag |
Organic compounds
|
|
US20040023390A1
(en)
|
2002-08-05 |
2004-02-05 |
Davidson Beverly L. |
SiRNA-mediated gene silencing with viral vectors
|
|
CA2400254A1
(en)
|
2002-09-19 |
2004-03-19 |
University Health Network |
Compositions and methods for treating heart disease
|
|
WO2004029055A1
(en)
|
2002-09-30 |
2004-04-08 |
Bayer Pharmaceuticals Corporation |
Fused azole-pyrimidine derivatives
|
|
BR0316386A
(pt)
|
2002-12-06 |
2005-09-27 |
Warner Lambert Co |
Benzoxazin-3-onas e seus derivados como inibidores de p13k
|
|
EP1581529A1
(en)
|
2002-12-20 |
2005-10-05 |
Warner-Lambert Company |
Benzoxazines and derivatives thereof as inhibitors of pi3ks
|
|
KR20070087266A
(ko)
|
2003-04-03 |
2007-08-28 |
세마포르 파머슈티컬즈, 아이엔씨. |
피아이-3 키나아제 억제제 프로드러그
|
|
WO2004108709A1
(en)
|
2003-06-05 |
2004-12-16 |
Warner-Lambert Company Llc |
Tetrazol benzofurancarboxamides with p13k aktivity as therapeutic agents
|
|
JP2006526614A
(ja)
|
2003-06-05 |
2006-11-24 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
治療用剤としての３−アリールスルファニル及び３−ヘテロアリールスルファニル置換ベンゾ［ｂ］チオフェン
|
|
EP1636210A1
(en)
|
2003-06-05 |
2006-03-22 |
Warner-Lambert Company LLC |
Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents
|
|
BRPI0411017A
(pt)
|
2003-06-05 |
2006-07-04 |
Warner Lambert Co |
indóis 3-substituìdos e derivados dos mesmos como agentes terapêuticos
|
|
US20040259926A1
(en)
|
2003-06-05 |
2004-12-23 |
Bruendl Michelle M. |
3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
|
|
CA2527341A1
(en)
|
2003-06-05 |
2004-12-16 |
Warner-Lambert Company Llc |
Cycloalkylsulfanyl substituted benzo[b]thiophenes as therapeutic agents
|
|
US20050043239A1
(en)
|
2003-08-14 |
2005-02-24 |
Jason Douangpanya |
Methods of inhibiting immune responses stimulated by an endogenous factor
|
|
WO2005016349A1
(en)
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Methods of inhibiting leukocyte accumulation
|
|
US20050239809A1
(en)
|
2004-01-08 |
2005-10-27 |
Watts Stephanie W |
Methods for treating and preventing hypertension and hypertension-related disorders
|
|
WO2005112935A1
(en)
|
2004-05-13 |
2005-12-01 |
Vanderbilt University |
Phosphoinositide 3-kinase delta selective inhibitors for inhibiting angiogenesis
|
|
USRE44638E1
(en)
|
2004-05-13 |
2013-12-10 |
Icos Corporation |
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
|
|
WO2005117889A1
(en)
|
2004-05-25 |
2005-12-15 |
Icos Corporation |
Methods for treating and/or preventing aberrant proliferation of hematopoietic
|
|
CN101123968A
(zh)
|
2004-06-04 |
2008-02-13 |
艾科斯有限公司 |
肥大细胞病的治疗方法
|
|
WO2006089106A2
(en)
|
2005-02-17 |
2006-08-24 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
|
US20090131512A1
(en)
|
2007-10-31 |
2009-05-21 |
Dynavax Technologies Corp. |
Inhibition of type I in IFN production
|
|
EP3427739A1
(en)
*
|
2008-11-13 |
2019-01-16 |
Gilead Calistoga LLC |
Therapies for hematologic malignancies
|
|
AU2009322187B2
(en)
|
2008-12-04 |
2015-02-19 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Phosphatidylinositol-3-kinase p110 delta-targeted drugs in the treatment of CNS disorders
|
|
JP5719779B2
(ja)
|
2008-12-24 |
2015-05-20 |
プラナ バイオテクノロジー リミティッド |
キナゾリノン化合物
|
|
PE20120602A1
(es)
|
2009-03-24 |
2012-05-21 |
Gilead Calistoga Llc |
ATROPISOMEROS DE 2-[(6-AMINO-9H-PURIN-9-IL)METIL]-5-METIL-3-o-TOLILQUINAZOLIN-4(3H)-ONA
|
|
ES2548253T3
(es)
|
2009-04-20 |
2015-10-15 |
Gilead Calistoga Llc |
Métodos para el tratamiento de tumores sólidos
|
|
US20110230465A1
(en)
|
2009-09-18 |
2011-09-22 |
Boehringer Ingleheim International Gmbh |
Viral polymerase inhibitors
|
|
AU2011265258A1
(en)
*
|
2010-06-11 |
2013-01-10 |
Calistoga Pharmaceuticals, Inc. |
Methods of treating hematological disorders with quinazolinone compounds in selected patients
|
|
WO2013082540A1
(en)
*
|
2011-12-02 |
2013-06-06 |
Gilead Calistoga Llc |
Compositions and methods of treating a proliferative disease with a quinazolinone derivative
|
|
IN2014DN07105A
(US20080094685A1-20080424-C00004.png)
|
2012-03-05 |
2015-04-24 |
Gilead Calistoga Llc |
|
|
CA2934534A1
(en)
|
2013-12-20 |
2015-06-25 |
Gilead Calistoga Llc |
Polymorphic forms of a hydrochloride salt of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one
|
